Impact of vitamin D supplementation and status on seizure frequency and quality of life in drug‐resistant epilepsy: A systematic review and meta‐analysis
Epileptic Disorders · 2026-10 · 28 (5) · 1431-1443
DOI: 10.1002/epd2.70294 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Epileptic Disorders, online erschienen am 01.06.2026. Verfasst von Bassel Alrabadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Vitamin D, Quality of Life, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background
Drug‐resistant epilepsy (DRE) affects approximately one‐third of patients with epilepsy and is associated with significant morbidity and reduced quality of life. Emerging evidence suggests that vitamin D may influence neuronal excitability and neuroinflammatory pathways, potentially impacting seizure control.
Objective
To systematically evaluate the effect of vitamin D supplementation and baseline vitamin D status on seizure frequency, biochemical outcomes, and quality of life in patients with drug‐resistant epilepsy.
Methods
PubMed, Scopus, and Web of Science were searched from inception through March 2026. Eligible studies assessed vitamin D supplementation or serum vitamin D levels in DRE patients.
Results
Eleven studies were included, with four studies ( n = 183) contributing to the meta‐analysis of supplementation outcomes. Vitamin D supplementation was associated with a significant reduction in seizure frequency (mean difference [MD] = −8.31 seizures/month, 95% CI [−13.38, −3.25], p = .001) and a significant increase in serum vitamin D levels (MD = 18.4 nmol/L, 95% CI [4.26, 32.54], p = .01). No significant difference in baseline vitamin D levels was observed between drug‐resistant and drug‐responsive epilepsy (MD = .79 nmol/L, 95% CI [−.31, 1.89], p = .16). Qualitative findings suggested potential improvements in quality of life and fatigue with long‐term supplementation, although short‐term effects and neuroinflammatory marker changes were inconsistent.
Conclusion
Vitamin D supplementation is a safe adjunctive therapy that may reduce seizure frequency in drug‐resistant epilepsy, though further large‐scale trials are needed to confirm its efficacy and define optimal use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
- Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
- Hamidiye International Faculty of Medicine, University of Health Sciences, Istanbul, Turkey.
ORCID-Profile: Bassel Alrabadi, Hasan I Matar
Zitieren
APA
Alrabadi, B., Matar, H. I., Bandak, N., Refai, Y., Alrabadi, F., & Alomari, O. (2026). Impact of vitamin D supplementation and status on seizure frequency and quality of life in drug‐resistant epilepsy: A systematic review and meta‐analysis. Epileptic Disorders, 28(5), 1431-1443. https://doi.org/10.1002/epd2.70294
Vancouver
Alrabadi B, Matar HI, Bandak N, Refai Y, Alrabadi F, Alomari O. Impact of vitamin D supplementation and status on seizure frequency and quality of life in drug‐resistant epilepsy: A systematic review and meta‐analysis. Epileptic Disorders. 2026;28(5):1431-1443. doi:10.1002/epd2.70294
BibTeX
@article{Alrabadi2026,
author = {Alrabadi, Bassel and Matar, Hasan I and Bandak, Natalie and Refai, Yamen and Alrabadi, Fadi and Alomari, Omar},
title = {Impact of vitamin D supplementation and status on seizure frequency and quality of life in drug‐resistant epilepsy: A systematic review and meta‐analysis},
journal = {Epileptic Disorders},
year = {2026},
volume = {28},
number = {5},
pages = {1431--1443},
doi = {10.1002/epd2.70294}
}
EUVIMED